• Skin and Hair Care
  • Beauty Advices
  • Mental Health
  • Medical News
Womens Secret Portal
for beauty bloggers
Medical News

A Closer Look at the Data Suggests Stopping Statins May Still Be Risky

by admin November 20, 2026
written by admin November 20, 2026

The atmosphere at the recent American Heart Association annual meeting was defined by a series of high profile neutral findings, leaving many in attendance wondering if established medical norms were shifting. Among the most discussed presentations was the STREAM trial, a study focusing on older adults without a prior history of heart attack or stroke. On the surface, the results seemed to suggest that these patients could stop taking their statins without seeing any significant difference in health outcomes compared to those who remained on the medication.

However, Dr. Vishal Khetpal, a preventive cardiologist and assistant professor at Northwestern University Feinberg School of Medicine, noticed something troubling when he looked closer at the actual data projections. While the study was framed as a noninferiority trial designed to see if stopping the drug was essentially as safe as continuing it, Khetpal observed that the visual curves showing patient outcomes actually diverged. In plain terms, this meant that while the result met a technical statistical threshold for noninferiority, it did not mean there was no difference between the two groups.

According to Khetpal’s analysis, those who were randomized to stop their statins actually fared worse than those who kept taking them. This discrepancy creates a confusing narrative where a study labeled as neutral might actually be signaling harm. The concern is serious enough that even the trial’s own data safety monitoring board recommended that participants who had ceased their medication consult with their physicians about starting it again.

For clinicians like Khetpal, this serves as a cautionary tale about how clinical trials are reported versus what they actually reveal. The gap between a technical finding of noninferiority and real world patient risk suggests that deprescribing statins may not be as benign as some initial interpretations of the STREAM trial imply. As physicians navigate these complex datasets, the priority remains ensuring that patients aren’t inadvertently stripped of protective therapies based on an overly optimistic reading of the numbers.

0 comment
0
FacebookTwitterPinterestEmail
admin

previous post
Sound Waves May Be the Secret to Better Dreams and Mental Recovery
next post
Public Health Crisis Deepens as Vaccine Skepticism Fuels Deadly Measles Surge

You may also like

My Week as a Kardashian

November 20, 2026

Public Health Crisis Deepens as Vaccine Skepticism Fuels...

November 20, 2026

A Forgotten Threat Returns As Newborns Face Rare...

November 19, 2026

A Lost Shield: Declining Vaccine Rates Lead to...

November 19, 2026

The Long Wait for Home in Room 3005

November 18, 2026

Public Health Alert Issued as Highly Contagious Bacteria...

November 18, 2026

Tuning In to the Brain’s Nightly Rinse Cycle

November 17, 2026

A Public Health Crisis Returns As America Teeters...

November 17, 2026

Public Health Crisis Deepens as Measles Outbreak Claims...

November 16, 2026

Breaking the Silence on Prostate Health With Updated...

November 16, 2026
Join The Exclusive Subscription Today And Get Premium Articles For Free


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Contacts
  • Email Whitelisting
  • Privacy Policy
  • Terms and Conditions

Copyright © 2026 WomensSecretPortal.com All Rights Reserved.


Back To Top
Womens Secret Portal
  • Skin and Hair Care
  • Beauty Advices
  • Mental Health
  • Medical News